|
1
|
Paget S: The distribution of secondary
growths in cancer of the breast. Lancet. 133:571–573.
1889.PubMed/NCBI
|
|
2
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee EY and Muller WJ: Oncogenes and tumor
suppressor genes. Cold Spring Harb Perspect Biol.
2(a003236)2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Seoane J and Gomis RR: TGF-β family
signaling in tumor suppression and cancer progression. Cold Spring
Harb Perspect Biol. 9(a022277)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004.
|
|
9
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Vanhaesebroeck B, Guillermet-Guibert J,
Graupera M and Bilanges B: The emerging mechanisms of
isoform-specific PI3K signalling. Nat Rev Mol Cell Biol.
11:329–341. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Goncalves MD, Hopkins BD and Cantley LC:
Phosphatidylinositol 3-kinase, growth disorders, and cancer. N Engl
J Med. 379:2052–2062. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hattori M: SIPA1 (signal-induced
proliferation-associated 1). Atlas of Genetics and Cytogenetics in
Oncology and Haematology, 2011.
|
|
14
|
Hattori M, Tsukamoto N, Nur-e-Kamal MS,
Rubinfeld B, Iwai K, Kubota H, Maruta H and Minato N: Molecular
cloning of a novel mitogen-inducible nuclear protein with a Ran
GTPase-activating domain that affects cell cycle progression. Mol
Cell Biol. 15:552–560. 1995.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kurachi H, Wada Y, Tsukamoto N, Maeda M,
Kubota H, Hattori M, Iwai K and Minato N: Human SPA-1 gene product
selectively expressed in lymphoid tissues is a specific
GTPase-activating protein for Rap1 and Rap2. Segregate expression
profiles from a rap1GAP gene product. J Biol Chem. 272:28081–28088.
1997.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Roberts MR, Hong CC, Edge SB, Yao S,
Bshara W, Higgins MJ, Freudenheim JL and Ambrosone CB: Case-only
analyses of the associations between polymorphisms in the
metastasis-modifying genes BRMS1 and SIPA1 and breast tumor
characteristics, lymph node metastasis, and survival. Breast Cancer
Res Treat. 139:873–885. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Crawford NP, Ziogas A, Peel DJ, Hess J,
Anton-Culver H and Hunter KW: Germline polymorphisms in SIPA1 are
associated with metastasis and other indicators of poor prognosis
in breast cancer. Breast Cancer Res. 8(R16)2006.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Gaudet MM, Hunter K, Pharoah P, Dunning
AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA,
Chanock S and Garcia-Closas M: Genetic variation in SIPA1 in
relation to breast cancer risk and survival after breast cancer
diagnosis. Int J Cancer. 124:1716–1720. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hsieh SM, Look MP, Sieuwerts AM, Foekens
JA and Hunter KW: Distinct inherited metastasis susceptibility
exists for different breast cancer subtypes: A prognosis study.
Breast Cancer Res. 11(R75)2009.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Brooks R, Kizer N, Nguyen L, Jaishuen A,
Wanat K, Nugent E, Grigsby P, Allsworth JE and Rader JS:
Polymorphisms in MMP9 and SIPA1 are associated with increased risk
of nodal metastases in early-stage cervical cancer. Gynecol Oncol.
116:539–543. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pei R, Xu Y, Wei Y, Ouyang T, Li J, Wang
T, Fan Z, Fan T, Lin B and Xie Y: Association of SIPA1 545 C>T
polymorphism with survival in Chinese women with metastatic breast
cancer. Front Med. 7:138–142. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ugenskienė R, Myrzaliyeva D, Jankauskaitė
R, Gedminaitė J, Jančiauskienė R, Šepetauskienė E and Juozaitytė E:
The contribution of SIPA1 and RRP1B germline polymorphisms to
breast cancer phenotype, lymph node status and survival in a group
of Lithuanian young breast cancer patients. Biomarkers. 21:363–370.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hsieh SM, Smith RA, Lintell NA, Hunter KW
and Griffiths LR: Polymorphisms of the SIPA1 gene and sporadic
breast cancer susceptibility. BMC Cancer. 9(331)2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gdowicz-Kłosok A, Giglok M, Drosik A,
Suwiński R and Butkiewicz D: The SIPA1-313A>G polymorphism is
associated with prognosis in inoperable non-small cell lung cancer.
Tumour Biol. 36:1273–1278. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xie C, Yang L, Yang X, Yang R, Li Y, Qiu
F, Chen M, Fang W, Bin X, Deng J, et al: Sipa1 promoter
polymorphism predicts risk and metastasis of lung cancer in
Chinese. Mol Carcinog. 52 (Suppl 1):E110–E117. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Zhang Y, Gong Y, Hu D, Zhu P, Wang N,
Zhang Q, Wang M, Aldeewan A, Xia H, Qu X, et al: Nuclear SIPA1
activates integrin beta1 promoter and promotes invasion of breast
cancer cells. Oncogene. 34:1451–1462. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Su L, Hattori M, Moriyama M, Murata N,
Harazaki M, Kaibuchi K and Minato N: AF-6 controls
integrin-mediated cell adhesion by regulating Rap1 activation
through the specific recruitment of Rap1GTP and SPA-1. J Biol Chem.
278:15232–15238. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Noda Y, Horikawa S, Furukawa T, Hirai K,
Katayama Y, Asai T, Kuwahara M, Katagiri K, Kinashi T, Hattori M,
et al: Aquaporin-2 trafficking is regulated by PDZ-domain
containing protein SPA-1. FEBS Lett. 568:139–145. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Alsarraj J, Faraji F, Geiger TR, Mattaini
KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, et
al: BRD4 short isoform interacts with RRP1B, SIPA1 and components
of the LINC complex at the inner face of the nuclear membrane. PLoS
One. 8(e80746)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Farina A, Hattori M, Qin J, Nakatani Y,
Minato N and Ozato K: Bromodomain protein Brd4 binds to
GTPase-activating SPA-1, modulating its activity and subcellular
localization. Mol Cell Biol. 24:9059–9069. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Park YG, Zhao X, Lesueur F, Lowy DR,
Lancaster M, Pharoah P, Qian X and Hunter KW: Sipa1 is a candidate
for underlying the metastasis efficiency modifier locus Mtes1. Nat
Genet. 37:1055–1062. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Shimizu Y, Hamazaki Y, Hattori M, Doi K,
Terada N, Kobayashi T, Toda Y, Yamasaki T, Inoue T, Kajita Y, et
al: SPA-1 controls the invasion and metastasis of human prostate
cancer. Cancer Sci. 102:828–836. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Takahara T, Kasamatsu A, Yamatoji M, Iyoda
M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M,
Tanzawa H and Uzawa K: SIPA1 promotes invasion and migration in
human oral squamous cell carcinoma by ITGB1 and MMP7. Exp Cell Res.
352:357–363. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ji K, Ye L, Toms AM, Hargest R, Martin TA,
Ruge F, Ji J and Jiang WG: Expression of signal-induced
proliferation-associated gene 1 (SIPA1), a RapGTPase-activating
protein, is increased in colorectal cancer and has diverse effects
on functions of colorectal cancer cells. Cancer Genomics
Proteomics. 9:321–327. 2012.PubMed/NCBI
|
|
35
|
Li JY, Wang JB, Liu CB, Ma DL and Ma JH:
Dynamic relationship between SIPA1 gene and protein expression and
the development of gastric cancer. Genet Mol Res.
16:2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mathieu V, Pirker C, Schmidt WM,
Spiegl-Kreinecker S, Lötsch D, Heffeter P, Hegedus B, Grusch M,
Kiss R and Berger W: Aggressiveness of human melanoma xenograft
models is promoted by aneuploidy-driven gene expression
deregulation. Oncotarget. 3:399–413. 2012.PubMed/NCBI View Article : Google Scholar
|
